Hyperhomocysteinemia in winter elite athletes: a longitudinal study
- PMID: 17598967
- DOI: 10.1007/BF03346312
Hyperhomocysteinemia in winter elite athletes: a longitudinal study
Abstract
Hyperhomocysteinemia is a well-established risk factor for cardiovascular diseases. The aims of this study were to longitudinally investigate, in a group of elite athletes, plasma homocysteine levels and to search for relationships with the muscular workload and the vitamin status. One hundred and three athletes (59 males and 44 females, respectively) were evaluated in different periods: namely the recovery period, the training period, and the competition period; 84 subjects (37 males and 47 females), served as controls. The evaluation sessions consisted in blood sampling and medical examination. The percentages of athletes with normal and elevated homocysteine levels, defined by levels below or above the limit of 15 mumol/l, were 68.0% and 32.0%, respectively, in the recovery period, and these percentages remained unchanged during the following periods. In the control group, relevant percentages were 92.9% and 7.1%, respectively. The comparison between plasma homocysteine of male and female, evaluated in the recovery period, showed significantly higher levels in the former group (18.8+/-18.0 micromol/l vs 10.7+/-5.9 micromol/l, p<0.001 respectively), as well as a higher proportion of individuals with hyperhomocysteinemia (24/59 vs 9/44, p<0.05). The correlation analyses showed a weak but significant negative correlation between homocysteine and folate in the three periods considered, while no significant relationship was observed between homocysteine and creatine-kinase. We found excess prevalence of hyperhomocysteinemia in elite athletes of winter sports. A strategy to understand which mechanisms in these athletes subserve hyperhomocysteinemia is essential in order to reduce the potential risk for future cardio-vascular morbidity and mortality.
Similar articles
-
The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.Kardiol Pol. 2003 Jul;59(7):17-26; discussion 26. Kardiol Pol. 2003. PMID: 14560345
-
Association of B vitamins status and homocysteine levels in elderly Taiwanese.Asia Pac J Clin Nutr. 2005;14(3):250-5. Asia Pac J Clin Nutr. 2005. PMID: 16169836
-
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].Nefrologia. 2005;25(3):288-96. Nefrologia. 2005. PMID: 16053010 Clinical Trial. Spanish.
-
DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.Clin Chem Lab Med. 2003 Nov;41(11):1392-403. doi: 10.1515/CCLM.2003.214. Clin Chem Lab Med. 2003. PMID: 14656016 Review.
-
The role of genetic factors in the development of hyperhomocysteinemia.Clin Chem Lab Med. 2003 Nov;41(11):1427-34. doi: 10.1515/CCLM.2003.219. Clin Chem Lab Med. 2003. PMID: 14656021 Review.
Cited by
-
Nutrition Assessment of B-Vitamins in Highly Active and Sedentary Women.Nutrients. 2017 Mar 26;9(4):329. doi: 10.3390/nu9040329. Nutrients. 2017. PMID: 28346362 Free PMC article.
-
Association of recreational physical activity with homocysteine, folate and lipid markers in young women.Eur J Appl Physiol. 2009 Jan;105(1):111-8. doi: 10.1007/s00421-008-0880-x. Epub 2008 Oct 14. Eur J Appl Physiol. 2009. PMID: 18853178
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources